Quinazolinone compounds in combined modalities for improved cancer treatment

Details for Australian Patent Application No. 2002366975 (hide)

Owner Collgard Biopharmaceuticals Ltd. Hadasit Medical Research Services and Development Ltd. Institute of Animal Science, Agricultural Research Org.

Inventors Pines, Mark; Yarkoni, Shai; Vlodavsky, Israel; Nagler, Arnon

Agent Griffith Hack

Pub. Number AU-B-2002366975

PCT Number PCT/IL02/01055

PCT Pub. Number WO2003/059355

Priority 147416 31.12.01 IL

Filing date 30 December 2002

Wipo publication date 30 July 2003

Acceptance publication date 13 December 2007

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/131 (2006.01) - acyclic

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/196 (2006.01)

A61K 31/198 (2006.01)

A61K 31/282 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4745 (2006.01)

A61K 31/475 (2006.01) - having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/52 (2006.01)

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/704 (2006.01)

A61K 31/7048 (2006.01)

A61K 31/7068 (2006.01)

A61K 33/24 Medicinal preparations containing inorganic active ingredients - Heavy metals

Event Publications

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2002366975

4 September 2003 Complete Application Filed

  Priority application(s): 147416 31.12.01 IL

13 December 2007 Application Accepted

  Published as AU-B-2002366975

10 April 2008 Standard Patent Sealed

23 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002366976-IFNAR2 mutants, their production and use

2002366974-METHODS OF INDUCING OR ENHANCING CONNECTIVE TISSUE REPAIR